# Lincosamides

Inhibit protein synthesis by disrupting the 50S ribosomal subunit. May be bacterostatic or bacteriocidal, depending on the concentration and the particular organism.

|Property|Clindamycin
|--|--|
|**Spectrum of Activity**|Gram positive cocci, anaerobes. Little action against gram negative aerobes. Also active against some protozoa, such as *P. falciparum*.
|**Route of Administration**|PO/IV
|**Dosing**|150-300mg Q6H
|**Absorption**|90% PO bioavailability
|**Distribution**|Excellent bony penetration
|**Metabolism**|Hepatic to active and inactive metabolites
|**Elimination**|Renal elimination of all metabolites
|**MSK**|May cause neuromuscular blockade in overdose
|**GIT**|Reasonable incidence of GIT upset, with fatal pseudomembranous colitis reported. Deranged LFTs
|**Immune**|Atopy, eosinophilia, DRESS

---
##References
1. Peck TE, Hill SA. Pharmacology for Anaesthesia and Intensive Care. 4th Ed. Cambridge University Press. 2014.  
2. Lexicomp. Clindamycin (systemic): Drug Information. In: UpToDate, Post, TW (Ed), UpToDate, Waltham, MA, 2017.